Clinical Trial Update: Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies [EARLY_Phase 1]

View source ↗

Summary

The document summarizes a Phase 1 trial of dose-adjusted EPOCH-R for mature B-cell malignancies, including Diffuse Large B-Cell Lymphoma, Post-Transplant Lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma
• Post-transplant Lymphoproliferative Disorder

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Diffuse Large B Cell Lymphoma, Post Transplant Lymphoproliferative Disorder | EARLY_Phase 1 | Status: COMPLETED